Published in Ann Surg on March 01, 1991
HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12
Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun (1999) 2.91
A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. PLoS Pathog (2007) 1.94
Thioredoxin reductase is essential for thiol/disulfide redox control and oxidative stress survival of the anaerobe Bacteroides fragilis. J Bacteriol (2007) 1.01
Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates. Antimicrob Agents Chemother (2004) 1.00
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother (2000) 0.98
Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol (2012) 0.98
Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB. Infect Immun (2006) 0.98
Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates. Antimicrob Agents Chemother (2005) 0.96
Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine (2011) 0.91
Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae. Infect Immun (1993) 0.87
Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages. Infect Immun (2012) 0.84
The nucleotide excision repair system of Borrelia burgdorferi is the sole pathway involved in repair of DNA damage by UV light. J Bacteriol (2013) 0.84
Inactivation of a single gene enables microaerobic growth of the obligate anaerobe Bacteroides fragilis. Proc Natl Acad Sci U S A (2012) 0.82
Carbon nanotube chemiresistor for wireless pH sensing. Sci Rep (2014) 0.81
The AirSR two-component system contributes to Staphylococcus aureus survival in human blood and transcriptionally regulates sspABC operon. Front Microbiol (2015) 0.80
Expression of Bacteroides fragilis hemolysins in vivo and role of HlyBA in an intra-abdominal infection model. Microbiologyopen (2013) 0.80
Hypoxia Attenuates Purinergic P2X Receptor-Induced Inflammatory Gene Expression in Brainstem Microglia. Hypoxia (Auckl) (2013) 0.79
Impact of lipopolysaccharide-induced inflammation on the disposition of the aminocephalosporin cefadroxil. Antimicrob Agents Chemother (2013) 0.78
The Response of Macrophages and Neutrophils to Hypoxia in the Context of Cancer and Other Inflammatory Diseases. Mediators Inflamm (2016) 0.77
Dps and DpsL Mediate Survival In Vitro and In Vivo during the Prolonged Oxidative Stress Response in Bacteroides fragilis. J Bacteriol (2015) 0.76
The Staphylococcus aureus AirSR Two-Component System Mediates Reactive Oxygen Species Resistance via Transcriptional Regulation of Staphyloxanthin Production. Infect Immun (2016) 0.76
Role of the HLA System in the Pathogenesis of Dupuytren's Disease. Hand (N Y) (2010) 0.76
Macrophage-mediated response to hypoxia in disease. Hypoxia (Auckl) (2014) 0.75
Bioengineered stem cells as an alternative for islet cell transplantation. World J Transplant (2015) 0.75
Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res (1980) 6.39
THE BACTERIAL FLORA OF ACUTE PERFORATED APPENDICITIS WITH PERITONITIS: A BACTERIOLOGIC STUDY BASED UPON ONE HUNDRED CASES. Ann Surg (1938) 4.67
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis (1977) 3.62
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Intra-abdominal abscesses. Am J Surg (1973) 2.14
Incidence and significance of intraperitoneal anaerobic bacteria. Ann Surg (1975) 1.79
The bacteriology of intra-abdominal infections. Surg Clin North Am (1975) 1.70
Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice. Infect Immun (1976) 1.64
Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun (1985) 1.35
Microbial synergism in human infections (second of two parts). N Engl J Med (1978) 1.17
Measurement of wound oxygen with implanted Silastic tube. Surgery (1972) 1.12
Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents. Br J Exp Pathol (1983) 1.06
Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots. Arch Surg (1984) 0.93
Continuous direct tissue oxygen tension measurement by a new method using an implantable silastic tonometer and oxygen polarography. Am J Surg (1983) 0.92
Intraperitoneal oxygen and carbon dioxide tensions in experimental adhesion disease and peritonitis. Am J Surg (1975) 0.86
Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity. Arch Surg (1987) 0.86
Oxygen and carbon dioxide tensions in the abdominal cavity and colonic wall of the rabbit. Am J Surg (1974) 0.83
A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med (1992) 3.95
Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med (2001) 2.41
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation (1996) 2.09
Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology (1996) 2.07
Endoscopic ultrasound drainage of pancreatic pseudocyst: a prospective comparison with conventional endoscopic drainage. Endoscopy (2006) 1.90
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant (2008) 1.69
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene (2001) 1.67
Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. Am Surg (1999) 1.61
The evolution and direction of OPTN oversight of live organ donation and transplantation in the United States. Am J Transplant (2008) 1.61
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis (1985) 1.51
Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology (2000) 1.50
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA (1999) 1.49
Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity. Am J Transplant (2009) 1.44
Thigh abscess. An uncommon presentation of intraabdominal sepsis. Am J Surg (1986) 1.41
Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg (2007) 1.39
Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches. Liver Transpl (2000) 1.39
A systems approach to surgical safety. Surg Endosc (2002) 1.34
Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. J Natl Cancer Inst (1986) 1.31
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis (2009) 1.29
Outpatient laparoscopic cholecystectomy: patient outcomes after implementation of a clinical pathway. Ann Surg (2001) 1.28
Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg (1986) 1.24
Mammalian bites. Compr Ther (1983) 1.15
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol (2007) 1.11
Electrical counting and sizing of mammalian cells in suspension: an experimental evaluation. Phys Med Biol (1967) 1.10
Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes. Ann Surg (1986) 1.10
Succinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function. Infect Immun (1985) 1.08
Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. Transplantation (2001) 1.07
Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains. Arch Surg (1999) 1.06
Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology (1998) 1.05
Fever patterns. Their lack of clinical significance. Arch Intern Med (1979) 1.04
Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg (2000) 1.04
Wound infections. Surg Clin North Am (1994) 1.04
Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States. Am J Kidney Dis (2000) 1.04
SRTR program-specific reports on outcomes: a guide for the new reader. Am J Transplant (2008) 1.02
A physical explantation of the bimodal distribution obtained by electronic sizing of erythrocytes. J Lab Clin Med (1969) 1.02
Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis. Endoscopy (2007) 1.02
Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant (2006) 1.00
Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index. Am J Transplant (2007) 0.99
Gastropleural fistula. Report of three cases and review of the literature. Am J Surg (1985) 0.98
Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis. Arch Surg (1985) 0.98
Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients: are outcomes worsened? Arch Surg (1999) 0.98
Identification of integrin-stimulated sites of serine phosphorylation in FRNK, the separately expressed C-terminal domain of focal adhesion kinase: a potential role for protein kinase A. Biochem J (1997) 0.96
Comparison of APACHE II scoring in liver and kidney transplant recipients versus trauma and general surgical patients in a single intensive-care unit. Clin Transplant (1995) 0.96
Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity. Liver Transpl (2000) 0.96
Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Transplant (1995) 0.95
Proposed thresholds for pancreatic tissue volume for safe intraportal islet autotransplantation after total pancreatectomy. Am J Transplant (2013) 0.94
Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun (2001) 0.93
Accuracy and significance of pretransplant liver volume measured by magnetic resonance imaging. Liver Transpl Surg (1996) 0.93
Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant (1999) 0.92
Diagnosis of intra-abdominal infection in the critically ill patient. Curr Opin Crit Care (2001) 0.92
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. Am J Physiol Cell Physiol (2013) 0.92
Percutaneous aspiration and drainage for suspected abdominal infection. Surgery (1984) 0.92
Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg (1992) 0.92
Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant (2000) 0.92
Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis. Infect Immun (2000) 0.92
Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill. Am Surg (1992) 0.91
Cecal volvulus: a different twist for the serious runner. N Engl J Med (1985) 0.91
Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg (1994) 0.91
Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential. Am J Transplant (2013) 0.90
Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect (Larchmt) (2001) 0.90
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group. Transplantation (1996) 0.89
Bacteremia associated with central venous catheter infection is not an independent predictor of outcomes. J Am Coll Surg (2000) 0.88
Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg (1998) 0.88
Surgical infection and the aging population. Am Surg (2001) 0.87
Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae. Infect Immun (1993) 0.87
Glucose metabolism after pancreas autotransplantation. The effect of open duct versus urinary bladder drainage technique. Ann Surg (1991) 0.87
Laparoscopic percutaneous jejunostomy for long term enteral access. Surg Endosc (1996) 0.87
Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation. Transplantation (1996) 0.86
Impact of bloodstream infection on outcomes among infected surgical inpatients. Ann Surg (2001) 0.86
Recurrent variceal bleeding after liver transplantation--persistent left-sided portal hypertension. Transplantation (1992) 0.86
Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis: VIII. A leukotoxin is produced by Escherichia coli metabolism in hemoglobin. Surgery (1984) 0.86
Cohort study of fever and leukocytosis as diagnostic and prognostic indicators in infected surgical patients. World J Surg (2001) 0.85
Intern call schedules and their relationship to sleep, operating room participation, stress, and satisfaction. Surgery (1999) 0.84
In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants. Infect Immun (1996) 0.84
Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism. Infect Immun (1998) 0.83
Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery (1996) 0.83
Communication gaps associated with donor-derived infections. Am J Transplant (2014) 0.83
Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function. Transplantation (1998) 0.83
The oversight of solid organ transplantation in the United States. Am J Transplant (2008) 0.82
Implications of 2,457 consecutive surgical infections entering year 2000. Ann Surg (2001) 0.82
Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation. Hepatology (1997) 0.82
The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies. Transplantation (1993) 0.81
Solubility and hemolytic activity of uranium trioxide. Environ Res (1979) 0.81
Early development of lactic acidosis with short term linezolid treatment in a renal recipient. J Chemother (2008) 0.81
Human sphincter of Oddi motility and cholecystokinin response following liver transplantation. Dig Dis Sci (1993) 0.81
Succinic acid production by Bacteroides fragilis. A potential bacterial virulence factor. Arch Surg (1987) 0.80
A Bacteroides by-product inhibits human polymorphonuclear leukocyte function. Arch Surg (1986) 0.80
Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation. J Med Vet Mycol (1995) 0.80
Biopsy needle characteristics assessed in the laboratory. Radiology (1983) 0.80